Hans van Houte
Director of Finance/CFO bij NURIX THERAPEUTICS, INC.
Vermogen: 843 913 $ op 29-02-2024
Profiel
Currently, Hans van Houte occupies the position of Chief Financial Officer for Nurix Therapeutics, Inc.
In the past he occupied the position of Chief Financial Officer for Igenica Biotherapeutics, Inc., Managing Partner at Bionation LLC, Chief Accounting Officer, Treasurer & Controller at Vertex Pharmaceuticals, Inc. and Vice President-Finance & Operations at Emergent Product Development Seattle.
Mr. Van Houte received an undergraduate degree from Babson College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NURIX THERAPEUTICS, INC.
0.14% | 16-02-2024 | 68 333 ( 0.14% ) | 843 913 $ | 29-02-2024 |
Actieve functies van Hans van Houte
Bedrijven | Functie | Begin |
---|---|---|
NURIX THERAPEUTICS, INC. | Director of Finance/CFO | 01-03-2016 |
Eerdere bekende functies van Hans van Houte
Bedrijven | Functie | Einde |
---|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Director of Finance/CFO | - |
Bionation LLC | Corporate Officer/Principal | - |
VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | - |
Opleiding van Hans van Houte
Babson College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
NURIX THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
Bionation LLC |